These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37188265)

  • 1. Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension.
    Blanco I; Marquina M; Tura-Ceide O; Ferrer E; Ramírez AM; Lopez-Meseguer M; Callejo M; Perez-Vizcaino F; Peinado VI; Barberà JA
    Front Pharmacol; 2023; 14():1145994. PubMed ID: 37188265
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of YM155 on the proliferation and apoptosis of pulmonary artery smooth muscle cells in a rat model of high pulmonary blood flow-induced pulmonary arterial hypertension.
    Ye B; Peng X; Su D; Liu D; Huang Y; Huang Y; Pang Y
    Clin Exp Hypertens; 2022 Jul; 44(5):470-479. PubMed ID: 35507763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted inhibition of survivin with YM155 promotes apoptosis of hypoxic human pulmonary arterial smooth muscle cells via the upregulation of voltage-dependent K⁺ channels.
    Zhang S; Liu B; Fan Z; Wang D; Liu Y; Li J; Wang N; Liu Y; Zhang B
    Mol Med Rep; 2016 Apr; 13(4):3415-22. PubMed ID: 26957114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of survivin expression on the apoptosis and proliferation of hypoxic human pulmonary arterial smooth muscle cells].
    Zhang S; Liu B; Zhang B; Fan Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2015 Jan; 38(1):45-9. PubMed ID: 25791656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YM155, a selective survivin inhibitor, reverses chronic hypoxic pulmonary hypertension in rats via upregulating voltage-gated potassium channels.
    Fan Z; Liu B; Zhang S; Liu H; Li Y; Wang D; Liu Y; Li J; Wang N; Liu Y; Zhang B
    Clin Exp Hypertens; 2015; 37(5):381-7. PubMed ID: 25856227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells.
    Tao YF; Lu J; Du XJ; Sun LC; Zhao X; Peng L; Cao L; Xiao PF; Pang L; Wu D; Wang N; Feng X; Li YH; Ni J; Wang J; Pan J
    BMC Cancer; 2012 Dec; 12():619. PubMed ID: 23267699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.
    McMurtry MS; Archer SL; Altieri DC; Bonnet S; Haromy A; Harry G; Bonnet S; Puttagunta L; Michelakis ED
    J Clin Invest; 2005 Jun; 115(6):1479-91. PubMed ID: 15931388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissues.
    Cheng XJ; Lin JC; Ding YF; Zhu L; Ye J; Tu SP
    Oncotarget; 2016 Feb; 7(6):7096-109. PubMed ID: 26771139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells.
    Liu P; Huang W; Ding Y; Wu J; Liang Z; Huang Z; Xie W; Kong H
    Drug Des Devel Ther; 2021; 15():1653-1666. PubMed ID: 33935492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension.
    Kudryashova TV; Goncharov DA; Pena A; Kelly N; Vanderpool R; Baust J; Kobir A; Shufesky W; Mora AL; Morelli AE; Zhao J; Ihida-Stansbury K; Chang B; DeLisser H; Tuder RM; Kawut SM; Silljé HH; Shapiro S; Zhao Y; Goncharova EA
    Am J Respir Crit Care Med; 2016 Oct; 194(7):866-877. PubMed ID: 27119551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.
    Kudryashova TV; Dabral S; Nayakanti S; Ray A; Goncharov DA; Avolio T; Shen Y; Rode A; Pena A; Jiang L; Lin D; Baust J; Bachman TN; Graumann J; Ruppert C; Guenther A; Schmoranzer M; Grobs Y; Eve Lemay S; Tremblay E; Breuils-Bonnet S; Boucherat O; Mora AL; DeLisser H; Zhao J; Zhao Y; Bonnet S; Seeger W; Pullamsetti SS; Goncharova EA
    Circ Res; 2022 Mar; 130(5):760-778. PubMed ID: 35124974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary study of biological mechanism and apoptotic effect induced by YM155 in SUDHL-4 cell line].
    Liang W; Zhang WJ; Gao QM; Qin W; Lu HN; Huang BB; Xiu B; Liang AB
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(10):700-4. PubMed ID: 22781300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells.
    Yan X; Su H
    Med Sci Monit; 2017 Apr; 23():1963-1972. PubMed ID: 28435150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension.
    Dabral S; Tian X; Kojonazarov B; Savai R; Ghofrani HA; Weissmann N; Florio M; Sun J; Jonigk D; Maegel L; Grimminger F; Seeger W; Savai Pullamsetti S; Schermuly RT
    Eur Respir J; 2016 Oct; 48(4):1137-1149. PubMed ID: 27471204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice.
    Alencar AKN; Pimentel-Coelho PM; Montes GC; da Silva MMC; Mendes LVP; Montagnoli TL; Silva AMS; Vasques JF; Rosado-de-Castro PH; Gutfilen B; Cunha VDMN; Fraga AGM; Silva PMRE; Martins MA; Ferreira TPT; Mendes-Otero R; Trachez MM; Sudo RT; Zapata-Sudo G
    Front Pharmacol; 2018; 9():1395. PubMed ID: 30574088
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines.
    Iwasa T; Okamoto I; Suzuki M; Nakahara T; Yamanaka K; Hatashita E; Yamada Y; Fukuoka M; Ono K; Nakagawa K
    Clin Cancer Res; 2008 Oct; 14(20):6496-504. PubMed ID: 18927289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
    Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
    Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
    Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.